Generated: November 22, 2017
DrugPatentWatch Database Preview
PROMETHAZINE HYDROCHLORIDE Drug Profile
What is the patent landscape for Promethazine Hydrochloride, and what generic Promethazine Hydrochloride alternatives are available?
is a drug marketed by Perrigo New York, Watson Labs, Taro, Ivax Sub Teva Pharms, Able, Teva, West-ward Pharms Int, Kvk Tech, Impax Labs, Pvt Form, Luitpold, Pharm Assoc, Abbott, Prinston Inc, Bedford Labs, Hi Tech Pharma, Tablicaps, G And W Labs, Sandoz, X-gen Pharms, Hospira, Vintage, Lannett, Teva Pharms Usa, Mylan, Sun Pharm Inds, Akorn, Marsam Pharms Llc, Sun Pharm Inds Inc, Mylan Institutional, Heritage Pharma, Tris Pharma Inc, Strides Pharma, Watson Labs Inc, Amneal Pharms Ny, Amneal Pharms, Wockhardt, Kv Pharm, Nostrum Labs Inc, Whiteworth Town Plsn, Zydus Pharms Usa, Actavis Mid Atlantic, Ani Pharms, and Hi-tech Pharma Co. and is included in eighty-seven NDAs.
The generic ingredient in PROMETHAZINE HYDROCHLORIDE is codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride. There are nineteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride profile page.
Summary for PROMETHAZINE HYDROCHLORIDE
Pharmacology for PROMETHAZINE HYDROCHLORIDE
|TABLET;ORAL||085664-001||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|INJECTABLE;INJECTION||084591-001||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|TABLET;ORAL||084233-001||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|INJECTABLE;INJECTION||040524-002||Mar 17, 2004||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|TABLET;ORAL||209177-002||Jun 30, 2017||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
Actavis Mid Atlantic
PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE
codeine phosphate; promethazine hydrochloride
|SYRUP;ORAL||088763-001||Oct 31, 1984||AA||RX||No||Yes||► Subscribe||► Subscribe||► Subscribe|
|SUPPOSITORY;RECTAL||040449-001||Feb 27, 2003||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
Zydus Pharms Usa
|TABLET;ORAL||040596-003||Nov 18, 2005||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
|INJECTABLE;INJECTION||083955-001||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|TABLET;ORAL||084539-001||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.